| Literature DB >> 35244778 |
Rafael Nakamura-Silva1, Louise Cerdeira2,3, Mariana Oliveira-Silva1, Karen Regina Carim da Costa4, Elder Sano5,6, Bruna Fuga5,6,7, Quézia Moura8, Fernanda Esposito6,7, Nilton Lincopan5,6,7, Kelly Wyres2, André Pitondo-Silva9,10.
Abstract
Klebsiella pneumoniae is an opportunistic pathogen that can cause several infections, mainly in hospitalised or immunocompromised individuals. The spread of K. pneumoniae emerging virulent and multidrug-resistant clones is a worldwide concern and its identification is crucial to control these strains especially in hospitals. This article reports data related to multi-resistant K. pneumoniae strains, isolated from inpatients in the city of Manaus, Brazil, harbouring virulence and antimicrobial-resistance genes, including high-risk international clones belonging to clonal group (CG) 258. Twenty-one strains isolated from different patients admitted to four hospitals in the city of Manaus, located in the state of Amazonas, Northern Brazil (Amazon Rainforest region) were evaluated. The majority of strains (61.9% n = 13) were classified as multidrug-resistant (MDR), and five strains (23.8%) as extensively drug-resistant (XDR). Several virulence and antimicrobial-resistance genes were found among the strains and eight strains (38.1%) presented the hyper-mucoviscous phenotype. MLST analysis demonstrated a great diversity of STs among the strains, totaling 12 different STs (ST11, ST23, ST198, ST277, ST307, ST340, ST378, ST462, ST502, ST3991, ST3993 and ST5209). Three of these (ST11, ST23 and ST340) belong to CG258.Entities:
Keywords: CG258; Hypermucoviscous; Klebsiella pneumoniae; Resistome; Virulome; WGS
Mesh:
Substances:
Year: 2022 PMID: 35244778 PMCID: PMC8894834 DOI: 10.1007/s00203-022-02813-0
Source DB: PubMed Journal: Arch Microbiol ISSN: 0302-8933 Impact factor: 2.667
Fig. 1Phenotypic and molecular characterisation of 21 Klebsiella pneumoniae isolates from clinical sources in Manaus, Brazil. Antimicrobials tested: amoxicillin–clavulanate (AMC), amikacin (AMI), ampicillin–sulbactam (APS), aztreonam (ATM), ceftazidime (CAZ), cefaclor (CFC), cefixime (CFM), cefoxitin (CFO), cefazolin (CFZ), ciprofloxacin (CIP), chloramphenicol (CLO), colistin (COL), cefepime (CPM), ceftriaxone (CRO), cefuroxime (CRX), ceftaroline (CTL), cefotetan (CTT), cefotaxime (CTX), doripenem (DOR), doxycycline (DOX), ertapenem (ERT), streptomycin (EST), fosfomicin (FOS), gentamicin (GEN), imipenem (IPM), levofloxacin (LEV), lomefloxacin (LMX), minocycline (MIN), meropenem (MPM), nalidixic acid (NAL), netilmicin (NET), nitrofurantoin (NIT), norfloxacin (NOR), ofloxacin (OFX), piperacillin–tazobactam (PIT), sulphonamide (SUL), trimethoprim–sulfamethoxazole (SUT), ticarcillin–clavulanate (TAC), tetracycline (TET), tobramycin (TOB), trimethoprim (TRI). aColored square: non-susceptible strains; blank squares: susceptible strains. No color was associated to polymyxins, since all strains analysed was susceptible to colistin. bXDR extensively drug-resistant, MDR multidrug-resistant, NC not classified. cFilled circles: detected; unfilled circles: not detected
Fig. 2Phylogenetic relations, resistome, virulome and plasmidome of 10 Klebsiella pneumoniae isolates from clinical sources in Manaus, Brazil. aOneBR ID refers to the ID of the isolates in the One Health Brazilian Resistance Integrated Genomic database (OneBR). bMutations in quinolone resistance determining regions. cQAC quaternary ammonium compounds